Fig 1: IL-9 is overexpressed in colonic biopsy specimens from patients with CAC. (A and B) Expression of IL-9 was examined by immunohistochemical staining of IL-9 in (A) CAC and (B) tumor-adjacent tissues. The number of IL-9-positive cells in the intestinal mucosa was significantly increased compared with that in paracancerous tissue. ***P<0.001. (C) Representative western blot and quantitative data demonstrating IL-9 expression in CAC and adjacent tissues. ***P<0.001. IL-9, interleukin-9; CAC, colitis-associated cancer.
Fig 2: IL-9 promotes RKO and Caco2 cell growth. (A and B) Compared with control group and LV-NC group, overexpression of IL-9 significantly promoted the proliferation of (A) RKO and (B) Caco2 cells. *P<0.05 compared with the control and LV-NC groups. IL-9, interleukin-9; CCK-8, Cell Counting Kit-8; LV, lentiviral vector; NC, negative control.
Fig 3: IL9 overexpression in RKO and Caco2 cells. (A) Infection efficiency as determined by light and fluorescence microscopy at 72 h postinfection in RKO and Caco2 cells. Scale bar, 50 µm. (B) IL-9 mRNA level in RKO and Caco2 cells following overexpression of IL-9. (C) The level of IL-9 protein in the cell culture supernatant following overexpression of IL-9 as determined by ELISA. The level of IL-9 protein was significantly increased following overexpression of IL-9. Data are presented as the mean values ± standard deviation. *P<0.05 and ***P<0.001. IL-9, interleukin-9.
Fig 4: IL-9 upregulates the expression of c-Myc and cyclinD1. (A and B) A significantincrease in the relative expression of (A) c-Myc and (B) cyclin D1 mRNA was observed in the LV-IL-9 group compared with control and LV-NC groups. (C-F) No significant difference was observed in the expression of (C) Bcl-2, (D) Bcl-xL, (E) surviving or (F) Mcl-1 between the LV-IL-9 and LV-NC groups. **P<0.01 and ***P<0.001. c-Myc, MYC proto-oncogene bHLH transcription factor; Bcl-2, B cell lymphoma-2; Bcl-xL, Bcl-2-associated X protein; Mcl-1, Induced myeloid leukemia cell differentiation protein Mcl-1 homolog; IL-9, interleukin-9; LV, lentiviral vector; NC, negative control.
Supplier Page from Abcam for Anti-IL-9 antibody